Released Mar 30, 2015, after the close
10-Q filed Mar 31, 2015, 274 days after period end · 0001193125-15-112307
Q2 2014 · 10-Q
Revenue$100.99M$100.99M +3.4% vs Q2 2013+1.0% vs Q1 2014
Net Income-$683.00K-$683.00K N/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.04-$0.04 N/M vs Q2 2013N/M vs Q1 2014
Gross Profit$75,571,000−0.2%
Operating Income$6,704,000−3.1%
Operating Cash Flowderived$28,086,000+47.2%
Free Cash Flowderived$25,639,000+108.7%
Margins · derived
Gross margin74.8%−2.8 pt vs Q2 2013
Operating margin6.6%−0.4 pt vs Q2 2013
Net margin-0.7%+2.4 pt vs Q2 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $100.99M | $97.64M | $111.60M | $108.22M |
| Net Income | -$683.00K | -$3.01M | $8.80M | $5.40M |
| EPS Diluted | -$0.04 | -$0.16 | $0.46 | $0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR